These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1023 related articles for article (PubMed ID: 34192610)

  • 1. Mucormycosis in COVID-19: A systematic review of cases reported worldwide and in India.
    Singh AK; Singh R; Joshi SR; Misra A
    Diabetes Metab Syndr; 2021; 15(4):102146. PubMed ID: 34192610
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Black fungus immunosuppressive epidemic with Covid-19 associated mucormycosis (zygomycosis): a clinical and diagnostic perspective from India.
    Singh K; Kumar S; Shastri S; Sudershan A; Mansotra V
    Immunogenetics; 2022 Apr; 74(2):197-206. PubMed ID: 34596728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diabetes, COVID 19 and mucormycosis: Clinical spectrum and outcome in a tertiary care medical center in Western India.
    Mishra Y; Prashar M; Sharma D; Akash ; Kumar VP; Tilak TVSVGK
    Diabetes Metab Syndr; 2021; 15(4):102196. PubMed ID: 34246939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rhino-orbital-cerebral-mucormycosis in COVID-19: A systematic review.
    Bhattacharyya A; Sarma P; Sharma DJ; Das KK; Kaur H; Prajapat M; Kumar S; Bansal S; Prakash A; Avti P; Thota P; Reddy DH; Gautam BS; Medhi B
    Indian J Pharmacol; 2021; 53(4):317-327. PubMed ID: 34414911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A systematic review of mucormycosis cases in COVID-19: Is it an unholy trilogy of COVID-19, diabetes mellitus, and corticosteroids?
    Kumar R; Misra AK; Dutta S; Gupta A; Kumar B; Charan J
    J Family Med Prim Care; 2022 Jun; 11(6):2573-2580. PubMed ID: 36119210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Absence of Case of Mucormycosis (March 2020-May 2021) under strict protocol driven management care in a COVID-19 specific tertiary care intensive care unit.
    Mulakavalupil B; Vaity C; Joshi S; Misra A; Pandit RA
    Diabetes Metab Syndr; 2021; 15(4):102169. PubMed ID: 34198110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiology and Pathophysiology of COVID-19-Associated Mucormycosis: India Versus the Rest of the World.
    Muthu V; Rudramurthy SM; Chakrabarti A; Agarwal R
    Mycopathologia; 2021 Dec; 186(6):739-754. PubMed ID: 34414555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COVID-19 associated mucormycosis - An emerging threat.
    Chao CM; Lai CC; Yu WL
    J Microbiol Immunol Infect; 2022 Apr; 55(2):183-190. PubMed ID: 35074291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COVID-19 and mucormycosis superinfection: the perfect storm.
    Al-Tawfiq JA; Alhumaid S; Alshukairi AN; Temsah MH; Barry M; Al Mutair A; Rabaan AA; Al-Omari A; Tirupathi R; AlQahtani M; AlBahrani S; Dhama K
    Infection; 2021 Oct; 49(5):833-853. PubMed ID: 34302291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. COVID-19-associated rhino-orbital-cerebral mucormycosis: A systematic review, meta-analysis, and meta-regression analysis.
    Bhattacharyya A; Sarma P; Kaur H; Kumar S; Bhattacharyya J; Prajapat M; Prakash A; Sharma S; Reddy DH; Thota P; Bansal S; Gautam BS; Medhi B
    Indian J Pharmacol; 2021; 53(6):499-510. PubMed ID: 34975140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. COVID-19-associated mucormycosis: An updated systematic review of literature.
    Pal R; Singh B; Bhadada SK; Banerjee M; Bhogal RS; Hage N; Kumar A
    Mycoses; 2021 Dec; 64(12):1452-1459. PubMed ID: 34133798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coronavirus disease-associated mucormycosis (CAM): A case control study during the outbreak in India.
    Wasiq M; K R; Gn A
    J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COVID-19 associated pulmonary mucormycosis: A systematic review of published cases with review of literature.
    Rai DK
    J Family Med Prim Care; 2022 Apr; 11(4):1244-1249. PubMed ID: 35516689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Various Treatment Modalities in COVID-19 Associated Facial Mucormycosis and the Need for its Surgical Management: A Systematic Review.
    Chopra S; Setiya S; Waknis PP; Kale L; Tidke S
    J Maxillofac Oral Surg; 2023 Mar; ():1-22. PubMed ID: 37362874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mucormycosis in COVID-19 patients.
    Sundaram N; Bhende T; Yashwant R; Jadhav S; Jain A
    Indian J Ophthalmol; 2021 Dec; 69(12):3728-3733. PubMed ID: 34827032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rampant Increase in Cases of Mucormycosis in India and Pakistan: A Serious Cause for Concern during the Ongoing COVID-19 Pandemic.
    Ghazi BK; Rackimuthu S; Wara UU; Mohan A; Khawaja UA; Ahmad S; Ahmad S; Hasan MM; Dos Santos Costa AC; Ahmad S; Essar MY
    Am J Trop Med Hyg; 2021 Aug; 105(5):1144-1147. PubMed ID: 34460426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased incidence of rhino-orbital mucormycosis in an educational therapeutic hospital during the COVID-19 pandemic in western Iran: An observational study.
    Avatef Fazeli M; Rezaei L; Javadirad E; Iranfar K; Khosravi A; Amini Saman J; Poursabbagh P; Ghadami MR; Parandin MM; Dehghani A; Ahmadi Jouybari T; Mahdavian B; Eivazi N; Rezaei S; Rezaei A; Emami B; Haqgou M; Bozorgomid A; Sayad B
    Mycoses; 2021 Nov; 64(11):1366-1377. PubMed ID: 34252988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pediatric mucormycosis associated with COVID-19: A systematic review of clinical cases.
    Amaral LB; Carlesse F; Rossato L
    Enferm Infecc Microbiol Clin (Engl Ed); 2024; 42(6):321-326. PubMed ID: 38216422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of Serum Iron Studies in COVID Associated Mucormycosis with Stage of the Disease.
    Rao C; R M
    J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. COVID-19 associated rhino-orbital-cerebral mucormycosis: An observational study from Eastern India, with special emphasis on neurological spectrum.
    Dubey S; Mukherjee D; Sarkar P; Mukhopadhyay P; Barman D; Bandopadhyay M; Pandit A; Sengupta A; Das S; Ghosh S; Adhikari S; Biswas PS; Pal P; Roy H; Patra N; Das A; Sinha P; Mondal MK; Shrivastava SR; Bhattacharya K; Mukhopadhyay M; Ahmed K; Halder TK; Saha M; Ahmed K; Maity S; Mandal A; Chatterjee D; Saha S; Chunakar A; Saha A; Ray BK
    Diabetes Metab Syndr; 2021; 15(5):102267. PubMed ID: 34509790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 52.